Every 10-Q that Exponent Inc (EXPO) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow EXPO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full EXPO filings page.
Exponent, Inc. delivered strong Q2 2026 results, with total revenues rising to $171.6 million from $141.9 million and revenues before reimbursements increasing to $148.9 million. Growth was driven mainly by the Engineering and Other Scientific segment and AI-related user research studies, including one large study equal to about 4% of net revenues. Net income grew to $29.4 million, diluted EPS to $0.60 from $0.52, and EBITDA to $42.7 million, or 28.7% of revenues before reimbursements.
For the first half of 2026, revenues reached $337.9 million and net income $59.0 million, with diluted EPS of $1.19. Operating cash flow was $29.9 million, while cash and equivalents fell to $66.6 million from $221.9 million, primarily due to increased share repurchases. The company spent $146.1 million buying back stock in six months, including 1.125 million shares in Q2 at an average $59.88, and declared cash dividends of $0.62 per share year to date. After quarter-end, the board approved another $0.31 dividend and authorized an additional $50 million share repurchase program.
Exponent, Inc. reported first-quarter 2026 revenue of $166.3 million, up 14.3% from $145.5 million a year earlier, driven by strong Engineering and Other Scientific work and AI-related user research and utility risk management projects. Revenues before reimbursements rose 10% to $151.8 million.
Net income increased 11% to $29.6 million, with diluted EPS rising to $0.59 from $0.52. EBITDA reached $43.1 million, and EBITDA as a percentage of revenues before reimbursements improved to 28.4%. The company returned capital through a $0.31 per-share dividend, Q1 share repurchases of about $78.8 million, and a new $50 million buyback authorization.
Exponent, Inc. (EXPO) reported higher Q3 results. Revenue rose to $147.1 million (up 8%) with revenues before reimbursements at $137.1 million (up 10%). Operating income increased to $29.0 million and net income reached $28.0 million, lifting diluted EPS to $0.55 from $0.50. Growth was driven by dispute-related work in energy, transportation, life sciences and construction, plus proactive risk management and regulatory consulting, partly offset by softer consumer electronics activity.
Cash and cash equivalents were $207.4 million as of October 3, 2025. For the first nine months, operating cash flow was $76.1 million, with $72.7 million used for share repurchases and $46.7 million for dividends. Subsequent to quarter-end, the Board approved a $0.30 per‑share dividend payable December 19, 2025, and authorized $100 million for additional share repurchases. Segment revenue grew across both Engineering & Other Scientific and Environmental & Health, with utilization modestly higher and billable hours up in the quarter.
Exponent reported modest top-line growth with mixed profitability. Second-quarter revenues were $141,962,000, up 1% year-over-year, driven by higher billing rates in engineering services. Net income fell 9% to $26,553,000 and diluted EPS declined to $0.52 from $0.57, reflecting higher compensation-related costs and lower utilization.
The firm generated $43,496,000 of operating cash flow in the first six months and held $231,801,000 in cash and cash equivalents at period end. Billable hours declined 6% and utilization fell to 72%, while a large change in the fair value of deferred compensation plan assets increased other income but also raised corporate compensation expense, materially reducing operating income for the quarter. The company continued shareholder returns via $0.30 per-share quarterly dividend and increased share repurchases ($32.68M year-to-date).